Advertisement
Canada markets closed
  • S&P/TSX

    21,554.86
    -26.44 (-0.12%)
     
  • S&P 500

    5,464.62
    -8.55 (-0.16%)
     
  • DOW

    39,150.33
    +15.53 (+0.04%)
     
  • CAD/USD

    0.7302
    -0.0004 (-0.05%)
     
  • CRUDE OIL

    80.59
    -0.70 (-0.86%)
     
  • Bitcoin CAD

    87,711.25
    -324.23 (-0.37%)
     
  • CMC Crypto 200

    1,319.45
    -40.88 (-3.01%)
     
  • GOLD FUTURES

    2,334.70
    -34.30 (-1.45%)
     
  • RUSSELL 2000

    2,022.03
    +4.64 (+0.23%)
     
  • 10-Yr Bond

    4.2570
    +0.0030 (+0.07%)
     
  • NASDAQ

    17,689.36
    -32.24 (-0.18%)
     
  • VOLATILITY

    13.20
    -0.08 (-0.60%)
     
  • FTSE

    8,237.72
    -34.74 (-0.42%)
     
  • NIKKEI 225

    38,596.47
    -36.53 (-0.09%)
     
  • CAD/EUR

    0.6826
    +0.0005 (+0.07%)
     

Company News for May 10, 2023

  • Shares of Duke Energy Corporation (DUK) declined 0.9% after the company reported first-quarter 2023 earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.29 per share.

  • Lumentum Holdings Inc.’s (LITE) shares fell 4% after the company reported third-quarter fiscal 2023 earnings of $0.75 per share, lagging the Zacks Consensus Estimate of $0.83 per share.

  • Shares of Atkore Inc. (ATKR) gained 0.5% after the company reported second-quarter fiscal 2023 earnings of $4.87 per share, beating the Zacks Consensus Estimate of $4.11 per share.

  • bluebird bio, Inc.’s (BLUE) shares jumped 12.6% after the company reported first-quarter 2023 earnings of $0.21 per share, surpassing the Zacks Consensus Estimate of a loss of $0.54 per share.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Duke Energy Corporation (DUK) : Free Stock Analysis Report

bluebird bio, Inc. (BLUE) : Free Stock Analysis Report

Lumentum Holdings Inc. (LITE) : Free Stock Analysis Report

Atkore Inc. (ATKR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research